1.90
price up icon1.60%   0.03
after-market 시간 외 거래: 1.91 0.01 +0.53%
loading
전일 마감가:
$1.87
열려 있는:
$1.9
하루 거래량:
160.73K
Relative Volume:
0.30
시가총액:
$99.70M
수익:
$21.05M
순이익/손실:
$-89.22M
주가수익비율:
-1.0615
EPS:
-1.79
순현금흐름:
$-64.50M
1주 성능:
+6.15%
1개월 성능:
-1.55%
6개월 성능:
-7.32%
1년 성능:
-66.49%
1일 변동 폭
Value
$1.80
$1.93
1주일 범위
Value
$1.63
$1.93
52주 변동 폭
Value
$1.02
$6.225

Tscan Therapeutics Inc Stock (TCRX) Company Profile

Name
명칭
Tscan Therapeutics Inc
Name
전화
857-399-9500
Name
주소
830 WINTER STREET, WALTHAM
Name
직원
210
Name
트위터
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
TCRX's Discussions on Twitter

TCRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TCRX
Tscan Therapeutics Inc
1.90 101.58M 21.05M -89.22M -64.50M -1.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
388.94 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.38 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
443.64 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
677.32 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
308.63 37.96B 3.81B -644.79M -669.77M -6.24

Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-16 개시 BTIG Research Buy
2024-05-13 개시 Needham Buy
2023-06-22 개시 Wedbush Outperform

Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스

pulisher
Aug 20, 2025

Does TScan Therapeutics Inc. fit your quant trading modelJuly 2025 Closing Moves & Technical Pattern Recognition Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

TScan Therapeutics Inc. recovery potential after sell offQuarterly Profit Report & Technical Entry and Exit Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Statistical indicators supporting TScan Therapeutics Inc.’s strengthJuly 2025 Institutional & Expert Approved Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Combining machine learning predictions for TScan Therapeutics Inc.July 2025 Earnings & Smart Investment Allocation Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Real time scanner hits for TScan Therapeutics Inc. explainedWeekly Investment Summary & Expert Approved Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Visualizing TScan Therapeutics Inc. stock with heatmapsJuly 2025 Short Interest & Weekly Breakout Watchlists - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Volatility clustering patterns for TScan Therapeutics Inc.Quarterly Market Summary & Free High Return Stock Watch Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Order flow analysis tools used on TScan Therapeutics Inc.Market Movement Recap & High Accuracy Buy Signal Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

TScan Therapeutics Inc. stock trend forecastPortfolio Performance Summary & Stepwise Swing Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Sector ETF performance correlation with TScan Therapeutics Inc.Volume Spike & Community Trade Idea Sharing - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

How high can TScan Therapeutics Inc. stock go2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

What moving averages say about TScan Therapeutics Inc.2025 Major Catalysts & Technical Entry and Exit Tips - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

What is Lifesci Capital’s Forecast for TCRX FY2025 Earnings? - Defense World

Aug 18, 2025
pulisher
Aug 17, 2025

Full technical analysis of TScan Therapeutics Inc. stockWall Street Watch & Risk Adjusted Buy/Sell Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Identifying reversal signals in TScan Therapeutics Inc.2025 Market Trends & Technical Buy Zone Confirmation - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

HC Wainwright Expects Higher Earnings for TScan Therapeutics - Defense World

Aug 17, 2025
pulisher
Aug 17, 2025

Detecting price anomalies in TScan Therapeutics Inc. with AIJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

What recovery options are there for TScan Therapeutics Inc.Portfolio Growth Summary & Stock Timing and Entry Methods - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

TScan Therapeutics Inc. Shows Support at Fibonacci LevelWatch List & Technical Entry and Exit Alerts - 선데이타임즈

Aug 16, 2025
pulisher
Aug 16, 2025

What are analysts’ price targets for TScan Therapeutics Inc.2025 Winners & Losers & Real-Time Volume Analysis - mustnews.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Measuring TScan Therapeutics Inc.’s beta against major indices2025 Market Overview & Precise Swing Trade Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What machine learning models say about TScan Therapeutics Inc.Layoff News & Smart Swing Trading Techniques - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What Fibonacci levels say about TScan Therapeutics Inc. reboundJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Equities Analysts Offer Predictions for TCRX Q3 Earnings - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

Intrinsic Value of TScan Therapeutics Inc. Stock: Is It Undervalued or OvervaluedMarket Performance Recap & Low Risk Growth Stock Ideas - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Should you hold or exit TScan Therapeutics Inc. now2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

TScan Therapeutics Inc. Breakout Confirmed by Volume MetricsJuly 2025 Review & Stepwise Entry/Exit Trade Alerts - 선데이타임즈

Aug 15, 2025
pulisher
Aug 15, 2025

What makes TScan Therapeutics Inc. stock price move sharplyGold Moves & Free Technical Pattern Based Buy Signals - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Is TScan Therapeutics Inc. a momentum stockDip Buying & Low Risk Entry Point Guides - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

TScan Therapeutics (NASDAQ:TCRX) Will Have To Spend Its Cash Wisely - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

TScan Therapeutics: Promising Developments and Strategic Advancements Drive Buy Rating - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Evaluating TScan Therapeutics Inc. with trendline analysisWeekly Trade Summary & Growth-Oriented Investment Plans - Newser

Aug 15, 2025

Tscan Therapeutics Inc (TCRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Tscan Therapeutics Inc 주식 (TCRX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Lynx1 Capital Management LP
10% Owner
May 20 '25
Buy
1.20
1,200,000
1,440,000
7,946,141
Lynx1 Capital Management LP
10% Owner
Dec 13 '24
Buy
2.90
100,000
290,140
5,357,347
Lynx1 Capital Management LP
10% Owner
Dec 12 '24
Buy
3.01
31,800
95,629
5,257,347
Lynx1 Capital Management LP
10% Owner
Nov 15 '24
Buy
4.34
947
4,114
5,225,547
Klencke Barbara
Director
Sep 23 '24
Buy
5.29
5,000
26,450
45,000
Klencke Barbara
Director
Aug 26 '24
Buy
5.53
5,000
27,650
40,000
$24.31
price down icon 1.38%
$84.76
price down icon 0.33%
$26.27
price up icon 0.27%
$105.07
price down icon 5.24%
$128.32
price down icon 2.70%
biotechnology ONC
$308.63
price down icon 1.61%
자본화:     |  볼륨(24시간):